William Blair Investment Management LLC Sells 418,757 Shares of Alignment Healthcare, Inc. $ALHC

Key Points

• William Blair Investment Management LLC has reduced its stake in Alignment Healthcare by 22.1%, selling 418,757 shares in the second quarter, leaving them with approximately 1.48 million shares worth around $20.7 million.
• Insiders sold a total of 7,443,207 shares of the company in the last three months, indicating significant movement among corporate stakeholders.
• Analyst ratings for Alignment Healthcare show a mix of evaluations, with two analysts giving a Strong Buy recommendation and others issuing Hold and Sell ratings.

William Blair Investment Management LLC lessened its position in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) by 22.1% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,478,571 shares of the company's stock after selling 418,757 shares during the quarter. William Blair Investment Management LLC owned about 0.75% of Alignment Healthcare worth $20,700,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of the stock. Vanguard Group Inc. grew its position in Alignment Healthcare by 13.2% during the 1st quarter. Vanguard Group Inc. now owns 11,113,896 shares of the company's stock worth $206,941,000 after purchasing an additional 1,295,825 shares during the last quarter. T. Rowe Price Investment Management Inc. grew its position in Alignment Healthcare by 5.0% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 9,078,113 shares of the company's stock worth $169,035,000 after purchasing an additional 429,071 shares during the last quarter. Wellington Management Group LLP grew its position in Alignment Healthcare by 0.9% during the 1st quarter. Wellington Management Group LLP now owns 7,509,057 shares of the company's stock worth $139,819,000 after purchasing an additional 70,557 shares during the last quarter. 8 Knots Management LLC grew its position in Alignment Healthcare by 28.9% during the 1st quarter. 8 Knots Management LLC now owns 4,715,472 shares of the company's stock worth $87,802,000 after purchasing an additional 1,056,777 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD grew its position in Alignment Healthcare by 9.7% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,199,421 shares of the company's stock worth $40,954,000 after purchasing an additional 193,644 shares during the last quarter. Hedge funds and other institutional investors own 86.19% of the company's stock.

Insider Activity

In related news, President Dawn Christine Maroney sold 215,662 shares of the stock in a transaction on Wednesday, September 10th. The shares were sold at an average price of $16.41, for a total transaction of $3,539,013.42. Following the sale, the president directly owned 1,797,237 shares of the company's stock, valued at approximately $29,492,659.17. This represents a 10.71% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Atlantic (Aln Hlth) L. General sold 6,246,096 shares of the stock in a transaction on Wednesday, September 17th. The stock was sold at an average price of $16.01, for a total transaction of $99,999,996.96. Following the sale, the director directly owned 24,596,079 shares in the company, valued at $393,783,224.79. This trade represents a 20.25% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 7,443,207 shares of company stock valued at $119,848,080 in the last three months. Corporate insiders own 6.60% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the stock. Wall Street Zen downgraded shares of Alignment Healthcare from a "buy" rating to a "hold" rating in a research report on Sunday, August 10th. KeyCorp raised shares of Alignment Healthcare from a "sector weight" rating to an "overweight" rating and set a $21.00 target price on the stock in a research report on Monday, August 25th. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Alignment Healthcare in a report on Wednesday, October 8th. Barclays raised shares of Alignment Healthcare from an "underweight" rating to an "equal weight" rating and upped their price objective for the company from $9.00 to $13.00 in a report on Thursday, July 31st. Finally, Zacks Research raised shares of Alignment Healthcare from a "hold" rating to a "strong-buy" rating in a report on Monday, September 29th. Two investment analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, Alignment Healthcare presently has an average rating of "Moderate Buy" and a consensus target price of $19.05.

Alignment Healthcare Stock Up 0.8%

ALHC stock opened at $17.12 on Monday. The firm's fifty day simple moving average is $16.40 and its 200-day simple moving average is $15.60. The company has a market capitalization of $3.39 billion, a P/E ratio of -61.14 and a beta of 1.18. The company has a debt-to-equity ratio of 2.29, a current ratio of 1.66 and a quick ratio of 1.66. Alignment Healthcare, Inc. has a 12 month low of $10.11 and a 12 month high of $21.06.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last announced its quarterly earnings results on Wednesday, July 30th. The company reported $0.07 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.07) by $0.14. Alignment Healthcare had a negative net margin of 1.53% and a negative return on equity of 43.68%. The firm had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $960.25 million. During the same period in the prior year, the firm posted ($0.13) earnings per share. The firm's quarterly revenue was up 49.0% compared to the same quarter last year. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. As a group, equities research analysts forecast that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Alignment Healthcare Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.